April 2 2022
The TestGene company has received a medical device registration certificate for the “HEPA-C-test-Q” kit for quantitative detection of the hepatitis C virus RNA
March 30 2022
The TestGene company has received a Registration certificate for the kit for qualitative detection of specific regions of the genomic DNA of the hepatitis B virus and RNA of the hepatitis C and D viruses
March 10 2022
The TestGene company has received a Registration certificate for the “COV-2-COLOR-TEST” kit for diagnostics of the SARS-COV-2 coronavirus infection by loop-mediated isothermal amplification (LAMP)
February 28 2022
On January 28, TestGene received the main award in the “Entrepreneur of the year” contest.
February 22 2022
The TestGene company has received a Registration certificate for the kits for screening hereditary tumor syndromes, determination of the strategy and effectiveness of treatment: "HRR-screening" and "BRCA1,2-diagnostics"
February 10 2022
The kit "CoV-2-dif-O" for qualitative detection of the SARS-CoV-2 coronavirus RNA with differentiation of the B.1.1.529 "Omicron" strain by real-time PCR has been registered
October 8 2019
Practical Significance of Prosta-Test Diagnostic Kit for Early Detection of Prostate Cancer was Acknowledged at the International Congress
September 25 2019
TestGene, LLC is a participant of Medica 2019, World Forum for Medicine, Dusseldorf, Germany, 18-21 November
Designed by